IBDEI2Y7 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,47050,1,4,0)
 ;;=4^M54.2
 ;;^UTILITY(U,$J,358.3,47050,2)
 ;;=^5012304
 ;;^UTILITY(U,$J,358.3,47051,0)
 ;;=R07.9^^181^2350^33
 ;;^UTILITY(U,$J,358.3,47051,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47051,1,3,0)
 ;;=3^Chest Pain,Unspec
 ;;^UTILITY(U,$J,358.3,47051,1,4,0)
 ;;=4^R07.9
 ;;^UTILITY(U,$J,358.3,47051,2)
 ;;=^5019201
 ;;^UTILITY(U,$J,358.3,47052,0)
 ;;=N20.0^^181^2350^16
 ;;^UTILITY(U,$J,358.3,47052,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47052,1,3,0)
 ;;=3^Calculus of Kidney
 ;;^UTILITY(U,$J,358.3,47052,1,4,0)
 ;;=4^N20.0
 ;;^UTILITY(U,$J,358.3,47052,2)
 ;;=^67056
 ;;^UTILITY(U,$J,358.3,47053,0)
 ;;=I69.910^^181^2350^24
 ;;^UTILITY(U,$J,358.3,47053,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47053,1,3,0)
 ;;=3^Cerebrovasc Disease w/ Attn/Concentration Deficit
 ;;^UTILITY(U,$J,358.3,47053,1,4,0)
 ;;=4^I69.910
 ;;^UTILITY(U,$J,358.3,47053,2)
 ;;=^5138660
 ;;^UTILITY(U,$J,358.3,47054,0)
 ;;=I69.911^^181^2350^27
 ;;^UTILITY(U,$J,358.3,47054,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47054,1,3,0)
 ;;=3^Cerebrovasc Disease w/ Memory Deficit
 ;;^UTILITY(U,$J,358.3,47054,1,4,0)
 ;;=4^I69.911
 ;;^UTILITY(U,$J,358.3,47054,2)
 ;;=^5138661
 ;;^UTILITY(U,$J,358.3,47055,0)
 ;;=I69.912^^181^2350^31
 ;;^UTILITY(U,$J,358.3,47055,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47055,1,3,0)
 ;;=3^Cerebrovasc Disease w/ Visuospatial Deficit/Spatial Neglect
 ;;^UTILITY(U,$J,358.3,47055,1,4,0)
 ;;=4^I69.912
 ;;^UTILITY(U,$J,358.3,47055,2)
 ;;=^5138662
 ;;^UTILITY(U,$J,358.3,47056,0)
 ;;=I69.913^^181^2350^29
 ;;^UTILITY(U,$J,358.3,47056,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47056,1,3,0)
 ;;=3^Cerebrovasc Disease w/ Psychomotor Deficit
 ;;^UTILITY(U,$J,358.3,47056,1,4,0)
 ;;=4^I69.913
 ;;^UTILITY(U,$J,358.3,47056,2)
 ;;=^5138663
 ;;^UTILITY(U,$J,358.3,47057,0)
 ;;=I69.914^^181^2350^26
 ;;^UTILITY(U,$J,358.3,47057,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47057,1,3,0)
 ;;=3^Cerebrovasc Disease w/ Frontal Lobe/Executive Function Deficit
 ;;^UTILITY(U,$J,358.3,47057,1,4,0)
 ;;=4^I69.914
 ;;^UTILITY(U,$J,358.3,47057,2)
 ;;=^5138664
 ;;^UTILITY(U,$J,358.3,47058,0)
 ;;=I69.915^^181^2350^25
 ;;^UTILITY(U,$J,358.3,47058,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47058,1,3,0)
 ;;=3^Cerebrovasc Disease w/ Cognitive Social/Emotional Deficit
 ;;^UTILITY(U,$J,358.3,47058,1,4,0)
 ;;=4^I69.915
 ;;^UTILITY(U,$J,358.3,47058,2)
 ;;=^5138665
 ;;^UTILITY(U,$J,358.3,47059,0)
 ;;=I69.918^^181^2350^28
 ;;^UTILITY(U,$J,358.3,47059,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47059,1,3,0)
 ;;=3^Cerebrovasc Disease w/ Other Sympt/Signs Involv Cognitive Functions
 ;;^UTILITY(U,$J,358.3,47059,1,4,0)
 ;;=4^I69.918
 ;;^UTILITY(U,$J,358.3,47059,2)
 ;;=^5138666
 ;;^UTILITY(U,$J,358.3,47060,0)
 ;;=I69.919^^181^2350^30
 ;;^UTILITY(U,$J,358.3,47060,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47060,1,3,0)
 ;;=3^Cerebrovasc Disease w/ Unspec Sympt/Signs Involv Cognitive Functions
 ;;^UTILITY(U,$J,358.3,47060,1,4,0)
 ;;=4^I69.919
 ;;^UTILITY(U,$J,358.3,47060,2)
 ;;=^5138667
 ;;^UTILITY(U,$J,358.3,47061,0)
 ;;=I50.30^^181^2350^5
 ;;^UTILITY(U,$J,358.3,47061,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47061,1,3,0)
 ;;=3^CHF Diastolic,Unspec
 ;;^UTILITY(U,$J,358.3,47061,1,4,0)
 ;;=4^I50.30
 ;;^UTILITY(U,$J,358.3,47061,2)
 ;;=^5007243
 ;;^UTILITY(U,$J,358.3,47062,0)
 ;;=I50.31^^181^2350^2
 ;;^UTILITY(U,$J,358.3,47062,1,0)
 ;;=^358.31IA^4^2
